🇪🇺 Rilutek in European Union

Rilutek (RILUZOLE) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/002622
  • Local brand name: Riluzole Zentiva
  • Status: approved

Rilutek in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in European Union

Frequently asked questions

Is Rilutek approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Rilutek in European Union?

Covis is the originator. The local marketing authorisation holder may differ — check the official source linked above.